Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis-Reference-Cited by-同舟云学术

Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis

Published:2016-09-26 Issue:2 Volume:240 Page:197-210
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Shimbori Chiko¹,Bellaye Pierre-Simon¹,Xia Jiaji¹,Gauldie Jack²,Ask Kjetil¹²^ORCID,Ramos Carlos³,Becerril Carina³,Pardo Annie⁴,Selman Moises³,Kolb Martin¹²

Affiliation:

1. Firestone Institute for Respiratory Health, Departments of Medicine; McMaster University; Hamilton Ontario Canada

2. Department of Pathology and Molecular Medicine; McMaster University; Hamilton Ontario Canada

3. Instituto Nacional de Enfermedades Respiratorias; México DF México Mexico

4. Facultad de Ciencias; Universidad Nacional Autónoma de México; Ciudad de México Mexico

Funder

Canadian Institutes of Health Research

Pulmonary Fibrosis Foundation

Canadian Pulmonary Fibrosis Foundation

Fonds de Dotation ‘Recherche en Santé Respiratoire’ et de la Fondation du Souffle

Research Institute of St Joe's Hamilton

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.4768/fullpdf

Reference49 articles.

1. INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;N Engl J Med,2014

2. ASCEND Study Group. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;N Engl J Med,2014

3. Host responses in tissue repair and fibrosis;Duffield;Annu Rev Pathol,2013

4. Fibrocytes in pulmonary fibrosis: a brief synopsis;Maharaj;Eur Respir Rev,2013

5. Molecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkers;Hambly;Respirology,2015

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Derazantinib Inhibits the Bioactivity of Keloid Fibroblasts via FGFR Signaling;Biomedicines;2023-12-05

2. lncRNA TUG1 as potential novel biomarker for prognosis of cardiovascular diseases;Epigenomics;2023-12

3. Cellular Transdifferentiation: A Crucial Mechanism of Fibrosis in Systemic Sclerosis;Current Rheumatology Reviews;2023-11-02

4. Emerging opportunities to treat idiopathic pulmonary fibrosis: Design, discovery, and optimizations of small-molecule drugs targeting fibrogenic pathways;European Journal of Medicinal Chemistry;2023-11

5. Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches;International Journal of Molecular Sciences;2022-11-29